• Abrahamsson, J., Clausen, N., Gustafsson, G., Hovi, L., Jonmundsson, G., Zeller, B., Forestier, E., Heldrup, J. & Hasle, H. (2007) Improved outcome after relapse in children with acute myeloid leukaemia. British Journal of Haematology, 136, 229236.
  • Abrahamsson, J., Forestier, E., Heldrup, J., Jahnukainen, K., Jónsson, Ó.G., Lausen, B., Palle, J., Zeller, B. & Hasle, H. (2011) Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate. Journal of Clinical Oncology, 29, 310315.
  • Aladjidi, N., Auvrignon, A., Leblanc, T., Perel, Y., Bénard, A., Bordigoni, P., Gandemer, V., Thuret, I., Dalle, J.H., Piguet, C., Pautard, B., Baruchel, A. & Leverger, G. (2003) Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucémie Aiquë Myéloïde Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology. Journal of Clinical Oncology, 21, 43774385.
  • Brethon, B., Yakouben, K., Oudot, C., Boutard, P., Bruno, B., Jérome, C., Nelken, B., de Lumley, L., Bertrand, Y., Dalle, J.H., Chevret, S., Leblanc, T. & Baruchel, A. (2008) Efficacy of fractionated gemtuzumab ozogamicin combined with cytarabine in advanced childhood myeloid leukaemia. British Journal of Haematology, 143, 541547.
  • Creutzig, U., Zimmermann, M., Bourquin, J.P., Dworzak, M.N., Fleischack, G., von Neuhoff, C., Sander, A., Schrauder, A., von Stackelberg, A., Ritter, J., Starý, J. & Reinhardt, D. (2011) CNS irradiation in pediatric acute myeloid leukemia: equal results by 12 or 18 Gy in studies AML-BFM98 and 2004. Pediatric Blood and Cancer, 57, 986992.
  • Formankova, R., Sedlacek, P., Keslová, P., Sramkova, L., Zizkova, H. & Stary, J. (2010) Adoptive immunotherapy, chemotherapy, and second allogeneic transplant in the treatment of post-transplant relapse of acute leukemia in children: a single center experience. Leukemia and Lymphoma, 51, 19361940.
  • Gibson, B.E., Webb, D.K., Howman, A.J., De Graaf, S.S., Harrison, C.J. & Wheatley, K. (2011) Results of a randomized trial in children with acute myeloid leukaemia: Medical Research Council AML12 trial. British Journal of Haematology, 155, 366376.
  • Goemans, B.F., Tamminga, R.Y., Corbijn, C.M., Hählen, K. & Kaspers, G.J. (2008) Outcome for children with relapsed acute myeloid leukemia in the Netherlands following initial treatment between 1980 and 1998: survival after chemotherapy only? Haematologica, 93, 14181420.
  • Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A. & Goldstone, A. (1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood, 92, 23222333.
  • Lie, S.O., Abrahamsson, J., Clausen, N., Forestier, E., Hasle, H., Hovi, L., Jonmundsson, G., Mellander, L. & Gustafsson, G. (2003) Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO-AML trials. British Journal of Haematology, 122, 217225.
  • Meshinchi, S., Leisenring, W.M., Carpenter, P.A., Woolfrey, A.E., Sievers, E.L., Radich, J.P. & Sanders, J.E. (2003) Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia. Biology of Blood and Marrow Transplantation, 9, 706713.
  • Muñoz, A., Badell, I., Olivé, T., Verdeguer, A., Gómez, P. & Bureo, E. (2002) Second allogeneic hematopoietic stem cell transplantation in hematologic malignancies in children: long-term results of a multicenter study of the Spanish Working Party for Bone Marrow Transplantation in Children (GETMON). Haematologica, 87, 331332.
  • Oda, M., Isoyama, K., Ito, E., Inoue, M., Tsuchida, M., Kigasawa, H., Kato, K. & Kato, S. (2009) Survival after cord blood transplantation from unrelated donor as a second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia. International Journal of Hematology, 89, 374382.
  • Rubnitz, J.E., Razzouk, B.I., Lensing, S., Pounds, S., Pui, C.-H. & Ribeiro, R.C. (2007) Prognostic factors and outcome of recurrence in childhood acute myeloid leukemia. Cancer, 109, 157163.
  • Sander, A., Zimmermann, M., Dworzak, M., Fleischhack, G., von Neuhoff, C., Reinhardt, D., Kaspers, G.J. & Creutzig, U. (2010) Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials. Leukemia, 24, 14221428.
  • Schmid, C., Schleuning, M., Aschan, J., Ringdén, O., Hahn, J., Holler, E., Hegenbart, U., Niederwieser, D., Dugas, M., Ledderose, G. & Kolb, H.J. (2004) Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation. Leukemia, 18, 14301433.
  • Schuster, F.R., Führer, M., Woessmann, W., Reiter, A., Harbott, J., Viehmann, S. & Borkhardt, A. (2005) Treatment of relapsed acute myelogeneous leukaemia with MLL/AF6 fusion after stem cell transplantation by intensive reinduction followed by adoptive immunotherapy. Leukemia, 19, 12731274.
  • Staffas, A., Kanduri, M., Hovland, R., Rosenquist, R., Ommen, H.B., Abrahamsson, J., Forestier, E., Jahnukainen, K., Jónsson, Ó.G., Zeller, B., Palle, J., Lönnerholm, G., Hasle, H., Palmqvist, L. & Ehrencrona, H. (2011) Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia. Blood, 118, 59055913.
  • Tempescul, A., Ianotto, J.C., Eveillard, J.R., Guillerm, G., Berthou, C., Marion, V. & De Braekeleer, M. (2008) High-dose melphalan followed by a second bone marrow transplantation in early relapse of acute myeloid leukemia after bone marrow transplantation in children. Annals of Hematology, 87, 503504.
  • Vettenranta, K., Hovi, L. & Saarinen-Pihkala, U.M. (2003) Adoptive immunotherapy as consolidation of remission in pediatric AML relapsing post-transplant. Pediatric Transplantation, 7, 446449.
  • Webb, D.K., Wheatley, K., Harrison, G., Stevens, R.F. & Hann, I.M. (1999) Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. Leukemia, 13, 2531.